Gilead Sciences (GILD) Total Debt Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
12.60% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
5.23% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-5.51% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
40.96% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-0.10% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
-11.13% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
3.78% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-10.56% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
8.30% |
| Date | Value |
| Mar 31, 2026 |
-11.13% |
| Dec 31, 2025 |
-6.65% |
| Sep 30, 2025 |
7.28% |
| Jun 30, 2025 |
6.84% |
| Mar 31, 2025 |
-0.96% |
| Dec 31, 2024 |
6.90% |
| Sep 30, 2024 |
-6.94% |
| Jun 30, 2024 |
-7.51% |
| Mar 31, 2024 |
-0.18% |
| Dec 31, 2023 |
-0.96% |
| Sep 30, 2023 |
-0.96% |
| Jun 30, 2023 |
-3.70% |
| Mar 31, 2023 |
-3.70% |
| Dec 31, 2022 |
-5.49% |
| Sep 30, 2022 |
-8.90% |
| Jun 30, 2022 |
-13.12% |
| Mar 31, 2022 |
-13.12% |
| Dec 31, 2021 |
-14.99% |
| Sep 30, 2021 |
-5.48% |
| Jun 30, 2021 |
25.20% |
| Mar 31, 2021 |
25.19% |
| Dec 31, 2020 |
27.69% |
| Sep 30, 2020 |
19.12% |
| Jun 30, 2020 |
-7.59% |
| Mar 31, 2020 |
-9.33% |
| Dec 31, 2019 |
-9.99% |
| Sep 30, 2019 |
-9.99% |
| Jun 30, 2019 |
-10.24% |
| Mar 31, 2019 |
-8.52% |
| Dec 31, 2018 |
-18.54% |
| Sep 30, 2018 |
-6.65% |
| Jun 30, 2018 |
10.51% |
| Mar 31, 2018 |
10.38% |
| Dec 31, 2017 |
27.31% |
| Sep 30, 2017 |
8.09% |
| Jun 30, 2017 |
18.84% |
| Mar 31, 2017 |
15.33% |
| Dec 31, 2016 |
19.46% |
| Sep 30, 2016 |
21.80% |
| Jun 30, 2016 |
80.28% |
| Mar 31, 2016 |
84.60% |
| Dec 31, 2015 |
77.81% |
| Sep 30, 2015 |
136.18% |
| Jun 30, 2015 |
29.14% |
| Mar 31, 2015 |
26.10% |
| Dec 31, 2014 |
86.92% |
| Sep 30, 2014 |
28.67% |
| Jun 30, 2014 |
29.53% |
| Mar 31, 2014 |
22.58% |
| Dec 31, 2013 |
-19.31% |
| Sep 30, 2013 |
-16.62% |
| Jun 30, 2013 |
-19.36% |
| Mar 31, 2013 |
-15.18% |
| Dec 31, 2012 |
8.11% |
| Sep 30, 2012 |
125.29% |
| Jun 30, 2012 |
134.62% |
| Mar 31, 2012 |
109.38% |
| Dec 31, 2011 |
118.29% |
| Sep 30, 2011 |
515.66% |
| Mar 31, 2011 |
63,433.06% |
| Dec 31, 2010 |
62,275.48% |
| Sep 30, 2010 |
207.56% |